Literature DB >> 22388939

Microcarrier-based expansion process for hMSCs with high vitality and undifferentiated characteristics.

Christiane L Elseberg1, Jasmin Leber, Denise Salzig, Christine Wallrapp, Moustapha Kassem, Matthias Kraume, Peter Czermak.   

Abstract

For cell therapy, a high biomass of human mesenchymal stem cells (hMSCs) is required for clinical applications, such as in the form of encapsulated implants. An easy and reproducible microcarrier-based stirred tank reactor cultivation process for hMSCs in 1.68 L scale is described. To avoid medium changes, studies comparing high-glucose DMEM (DMEM-HG) with low-glucose EMEM were performed showing that high-glucose medium has positive effects on cell proliferation and that cell differentiability remains. Studies on the inoculation strategy and cell density, carrier concentration, volume, and stirrer speed were performed and resulted in a set of optimized parameters, inoculation strategy was found to be 45 minutes of static state and 2 minutes of stirring repeated in 4 cycles. The inoculation density was chosen to be 7×10³ cells/cm2, and the carrier concentration of glass surface carrier was 25 g/L. For the described reactor system, a stirrer speed of 120 rpm for the inoculation process and a daily increase of 10 rpm up to 160 rpm were found to be suitable. Process reproducibility was shown by 3 repeated cultivations at the determined set of parameters allowing high biomass values of up to 7×10⁸ cells per batch. With DMEM-HG, no limitation of glucose was found, and lactate and ammonia remained lower than critical inhibitory concentrations. Comparison of the static (T-flask) and dynamic cultures in the stirred tank reactor showed for both cases, that cells were of high vitality and both maintained differentiability. In both cases, encapsulation of the cells resulted in high bead vitality, a basic requirement for cell therapy application.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22388939     DOI: 10.5301/ijao.5000077

Source DB:  PubMed          Journal:  Int J Artif Organs        ISSN: 0391-3988            Impact factor:   1.595


  11 in total

1.  Nutrient Regulation by Continuous Feeding for Large-scale Expansion of Mammalian Cells in Spheroids.

Authors:  Bradley P Weegman; Ahmad Essawy; Peter Nash; Alexandra L Carlson; Kristin J Voltzke; Zhaohui Geng; Marjan Jahani; Benjamin B Becker; Klearchos K Papas; Meri T Firpo
Journal:  J Vis Exp       Date:  2016-09-25       Impact factor: 1.355

Review 2.  Adverse effect of high glucose concentration on stem cell therapy.

Authors:  Najmaldin Saki; Mohammad Ali Jalalifar; Masoud Soleimani; Saeideh Hajizamani; Fakher Rahim
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2013

Review 3.  Three-Dimensional Bioreactor Technologies for the Cocultivation of Human Mesenchymal Stem/Stromal Cells and Beta Cells.

Authors:  Florian Petry; Tobias Weidner; Peter Czermak; Denise Salzig
Journal:  Stem Cells Int       Date:  2018-03-14       Impact factor: 5.443

Review 4.  Biological Considerations in Scaling Up Therapeutic Cell Manufacturing.

Authors:  Darshana S Cherian; Tejasvini Bhuvan; Laurence Meagher; Tracy S P Heng
Journal:  Front Pharmacol       Date:  2020-05-13       Impact factor: 5.810

5.  Micro computed tomography with and without contrast enhancement for the characterization of microcarriers in dry and wet state.

Authors:  Sébastien de Bournonville; Liesbet Geris; Greet Kerckhofs
Journal:  Sci Rep       Date:  2021-02-02       Impact factor: 4.379

6.  Large scale expansion of human umbilical cord cells in a rotating bed system bioreactor for cardiovascular tissue engineering applications.

Authors:  Anne Reichardt; Bianca Polchow; Mehdi Shakibaei; Wolfgang Henrich; Roland Hetzer; Cora Lueders
Journal:  Open Biomed Eng J       Date:  2013-06-14

7.  Enzymatic detachment of therapeutic mesenchymal stromal cells grown on glass carriers in a bioreactor.

Authors:  Denise Salzig; Alexandra Schmiermund; Pablo P Grace; Christiane Elseberg; Christian Weber; Peter Czermak
Journal:  Open Biomed Eng J       Date:  2013-12-27

8.  Manufacturing Cells for Clinical Use.

Authors:  Mark L Weiss; Mahendra S Rao; Robert Deans; Peter Czermak
Journal:  Stem Cells Int       Date:  2016-06-12       Impact factor: 5.443

Review 9.  Regenerative Therapy of Type 1 Diabetes Mellitus: From Pancreatic Islet Transplantation to Mesenchymal Stem Cells.

Authors:  Nadine E Rekittke; Meidjie Ang; Divya Rawat; Rahul Khatri; Thomas Linn
Journal:  Stem Cells Int       Date:  2016-03-07       Impact factor: 5.443

10.  Manufacturing of Human Umbilical Cord Mesenchymal Stromal Cells on Microcarriers in a Dynamic System for Clinical Use.

Authors:  Florian Petry; J Robert Smith; Jasmin Leber; Denise Salzig; Peter Czermak; Mark L Weiss
Journal:  Stem Cells Int       Date:  2016-02-08       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.